share_log

Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $100

Benzinga ·  Nov 20 20:15  · Ratings

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and raises the price target from $98 to $100.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment